Organon (OGN) Tops Q2 EPS by 34c; offers guidance

Organon (NYSE: OGN) reported Q2 EPS of $1.31, $0.34 better than the analyst estimate of $0.97. Revenue for the quarter came in at $1.61 billion versus the consensus estimate of $1.57 billion.

GUIDANCE:

Organon sees FY2023 revenue of $6.25-6.45 billion, versus the consensus of $6.28 billion.

For earnings history and earnings-related data on Organon (OGN) click here.

You May Also Be Interested In

• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Hyperscale Data launches $300M at-the-market stock offering
• FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group